A VIMP plot identified SMOC1 as the top‐ranked contributor to the model; this gene has been previously associated with metastatic potential in pancreatic neuroendocrine tumors.[31] Genes such as FAT1 and MAFK, which are associated with poor tumor prognosis,[32] were also highly expressed in the low LIRA‐score group. The gene discussed is FAT1; the disease is pancreatic neuroendocrine tumor.